# Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

> **NCT02308332** · PHASE4 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 58 (actual)

## Conditions studied

- Neurocognitive Decline
- HIV Associated Neurocognitive Disorder

## Interventions

- **DRUG:** Eviplera

## Key facts

- **NCT ID:** NCT02308332
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02308332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02308332, "Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02308332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*